Dr. Catherine Tisdall, MD
Dermatologist
8431 Fredericksburg Rd #100 San Antonio TX, 78229About
I am part of a well established and respected dermatology private practice. We have three locations to serve San Antonio; Shavano Park, Helotes, and Westover Hills. I offer the highest quality care to patients with the full spectrum of dermatologic conditions. I see patients of all ages from kids to the elderly. I enjoy practicing medical, surgical, and cosmetic dermatology. This means I take care of patients with everything from acne to melanoma. My practice also offers patch testing to help manage patients with dermatitis, narrow band UVB to help with inflammatory skin diseases, and ALA-PDT to help patients with precancerous growths known as AKs. My office also offers a full menu of cometic services from light chemical peels and non-invasive body sculpting with my aesthtician to fractional CO2 resurfacing, botox and fillers administered by myself. I am a certified Expert Injector which reflects my expertise in non-invasive facial rejuventaion. Lastly we also participate in clinical trials of medications to treat a variety of dermatologic conditions like acne, psoriasis and actinic keratoses.
Education and Training
University of Washington School of Medicine
University of Washington School of Medicine 2002
Board Certification
American Board of Dermatology- Dermatology
DermatologyAmerican Board of DermatologyABD
Provider Details
Areas of expertise and specialization
Faculty Titles & Positions
- Local Public Speaking -
- Former Assistant Professor of Dermatology, Penn State -
Awards
- America's Top Dermatologist 2009, 2010, 2011, 2013
- Patients' Choice Award 2010, 2011, 2012
- Texas Rising Stars 2012, 2013
- Peer Reviewed Physicians 2013
- Most Compassionate Doctor 2011
- S.A. Doctors, Best of 2013, 2014
- 2005 Medical Dermatology Society Mentorship, Dr. Werth, U of Pennsylvania
- 2002 Graduation with Honors, University of Washington Medical School
Treatments
- Acne
- Eczema
- Dermatitis
- Rosacea
- Moles
- Seborrheic Dermatitis
- Actinic Keratosis
- Birthmark
- Contact Dermatitis
- Fungal Infection
- Nail Fungus
- Rash
- Seborrheic Keratosis
- Natural Hormone Balancing
Areas of research
Research Experience2012 - Sub- Investigator, A Phase 3 Study to Evaluate the Efficacy and
Safety of Induction and Maintenance Regimens of an Investigational
Injectable Medication Compared With Placebo and An Approved
Injectable Medication in Subjects With Moderate to Severe Plaque
Psoriasis.
2012 - Sub-Investigator, A 12-Week Multicenter, Randomized, Double-
Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of an Investigational Injectable Medication to an Approved Injectable Medication and Placebo in Patients With Moderate to Severe Plaque Psoriasis With a Long-Term Extension Period.
2012 – 2013 Sub-Investigator, A Randomized, double-Blind, Multiple-Site,
Placebo-Controlled, Parallel Design Study comparing two topical gels in
the treatment of Actinic Keratosis.
2012 - Sub-Investigator, A Randomized, Multi-Center, Investigator-Blind, Vehicle-and Active-Controlled, Phase 2 Study To Assess The Efficacy And Safety Of Different Concentrations of A Topical Cream Applied Once Daily in subjects With Moderate To Severe Acne Vulgaris.
2012 – 2013 Sub-Investigator, A Phase 3 Randomized, a 12-week Vehicle-Controlled, Parallel-group Study Assessing the Efficacy and Safety of a Topical medication in Subjects with Papulopustular Rosacea, followed by a 40 Week Investigator-Blinded Extension Comparing the Long-term Safety of a Topical Cream Versus a Gel.
2011 -2012 Sub-Investigator, A Randomized, Double-blind, Placebo-Controlled,
Multiple-site, Study Comparing 2 Topical Gels in the Treatment of Moderate to Severe Rosacea.
2011- 2012 Sub-Investigator, An Open-Label Study to Evaluate the Safety of Long-Term Administration of a Topical Cream in Subjects With Tinea Pedis, Tinea Corporis, or Tinea Cruris.
2011 - 2012 Sub-Investigator, A Randomized, Multi-Center, Double-Blind, Vehicle-controlled Study Evaluating the Efficacy And Safety of a Topical Cream in Subjects With Tinea Pedis.
2011 - Sub-Investigator, A Randomized, Double-Blind, Double-dummy, Placebo Controlled, Multicenter Study of an Injectable Medication to Demonstrate Efficacy After 12 Weeks of Treatment, Compared to Placebo and an Injectable Medication, and to Assess the Safety , Tolerability and Long-term Efficacy up to One year In Subjects With Moderate to Severe Chronic Plaque –Type Psoriasis. 4
2011 – 2012 Sub-Investigator, A Randomized, Multi-Center, Double-Blind, Vehicle-Controlled Study evaluating the Efficacy and Safety of a Topical medication in Subjects with Tinea Cruris.
2011 – 2012 Sub-Investigator, a Multi-Center, Randomized, Double-Blind, Placebo-
Controlled, 3-Arm, Parallel Group Study comparing the Efficacy and Safety of an oral medication versus placebo and an antibiotic once daily in the Treatment of Inflammatory Lesions in Subjects with Acne Vulgaris.
2011 - Sub-Investigator, A Phase 3, Multi-Site, Open-Label Study of the Long Term Safety and Tolerability of 2 Doses of an Oral Medication in Subjects With Moderate To Severe Chronic Plaque Psoriasis.
2010 - 2013 Sub-Investigator, A Phase 3, Multi-Site, Randomized, Mixed-Blind, Parallel-Group Treatment Withdrawal and Re-treatment Study of the Efficacy and Safety of an oral medication in Subjects With Moderate to Severe Chronic Plaque Psoriasis.
2009- 2011 Sub-Investigator, A Phase 3, Multicenter, Randomized, Double-Blind Study Evaluating the Safety and Efficacy of a topical solution versus Vehicle in Subjects with Mild to Moderate Onychomycosis of the Toenails.
2009- 2011 Sub-Investigator, A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of adding an oral medication to an injectable medication in Subjects With Moderate to Severe Plaque Psoriasis.
2009- 2011 Sub-Investigator, A double-blind, randomized, Phase 3, parallel group study evaluating the efficacy and safety of an oral medication in patients with severe recalcitrant nodular acne.
2009-2009 Sub-Investigator, A Phase 3, double-blind, randomized, parallel-group, vehicle- controlled, multicenter study to compare the safety and efficacy of a topical medication in the treatment of Actinic Keratosis.
2008-2009 Sub- Investigator, A Phase 3, multicenter, randomized, controlled,
parallel-group study comparing the efficacy of a topical medication associated with an oral medication in the treatment of severe acne vulgaris.
Dr. Catherine Tisdall, MD's Practice location
San Antonio, TX 78229Get Direction
Dr. Catherine Tisdall, MD's reviews
Write ReviewRecommended Articles
- How Exactly Does Terbinafine Work to Treat Jock Itch?
What is terbinafine?Terbinafine is an antifungal that works by stopping fungi from growing. Topical terbinafine is used for the treatment of fungal skin infections, such as ringworm, jock itch, and athlete's foot. Oral terbinafine tablets are often prescribed when it comes to treating fungal...
- How to Get Rid of Your Acne
Acne is often treated as a common beauty problem, but the fact is that it is far beyond a superficial skin problem.Although it is a very common skin problem and is not dangerous, it can sometimes end up leaving unsightly scars that can take a toll on confidence and self esteem. Acne is one of the...
- What Causes Heat Rash?
Heat rash, prickly heat, or miliaria is a condition that results from the blockage of the sweat ducts. This condition usually affects people living in hot and humid places. As a result of the blocked pores of the skin (sweat ducts), perspiration is trapped under the skin. Once sweat is stuck in the...
- What is Scabies?
Scabies is a skin disease caused by the infestation of the mite, Sarcoptes scabiei. These organisms are too small to be seen with naked eye. Infestation by this mite is common worldwide. People of all age groups may be affected by this skin condition and is very common in areas that are congested,...
- How Is Heat Rash Diagnosed?
Heat rash is a skin condition that is also called as "miliaria". It occurs as a result of excessive sweating that leads to the blocking of sweat glands. Once your sweat glands are blocked, sweat accumulates in the skin layers causing rashes. Most the symptoms of this condition are characterized by...
- Treatments for Heat Rash
Heat rash, prickly heat, or miliaria is a condition of the skin that causes rash mostly because of excess sweating. It is a condition that occurs if the sweat ducts cannot efficiently excrete sweat from the body. As a result, sweat accumulates within the skin layers causing a rash that is...
Nearby Providers
- Dr. Ana Trevino Sauceda M.D.2829 BABCOCK RD SAN ANTONIO TX 78229
- Dr. Terri J Nutt MD7434 Louis Pasteur San Antonio TX 78229
- Dr. John Joseph Gonzalez M.D.2829 BABCOCK RD STE 629 SAN ANTONIO TX 78229
- Dr. John Caleb Browning MD7703 Floyd Curl Dr San Antonio TX 78229
- Dr. Susan J Mahler M.D.7810 Louis Pasteur San Antonio TX 78229
- Dr. Steven Andrew Davis MD7810 Louis Pasteur Dr San Antonio TX 78229